# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Sep 2, 2025

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 16:02 ET
- Period: 2025-09-02
- Accession: 0000879407-25-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000087940725000004/arwr-20250902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000087940725000004/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000087940725000004/arwr-20250902.htm

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000879407-25-000004. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.